Trial intelligence / Profile preview

Chamomile Gel vs Urea Cream for Radiodermatitis

NCT02247830Phase 3Completed

Sponsor
University of Brasília
Start
Jul 2015
Primary completion
May 2017
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of chamomilla recutita topical formulation and urea + glycerol cream in radiodermatitis (3 arms), sponsored by University of Brasília. Primary endpoint: Occurrence of radiodermatitis at 5 weeks. Started Jul 2015; status: completed.

02

Drugs

chamomilla recutita topical formulationurea + glycerol cream
03

Conditions

radiodermatitis

Beyond the preview

Go deeper on NCT02247830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02247830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call